Kim Byong 4
4 · LIPELLA PHARMACEUTICALS INC · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Kim Byong
Director
Transactions
- Award
Stock Options
2023-06-16+25,000→ 25,000 totalExercise: $2.19From: 2023-06-16Exp: 2033-06-16→ Common Stock (25,000 underlying)